Opinion: AI Is Pushing the I&I Pendulum From Biologics to Small Molecules
Drug development powered by artificial intelligence is countering incentives from the Inflation Reduction Act and making small molecules more attractive in the complex inflammatory & immunology disease space.
Opinion: AI Is Pushing the I&I Pendulum From Biologics to Small Molecules Read More »
